Cholangiocarcinoma: Era of Immune Check-Point Inhibitors

被引:0
|
作者
El Hag, Mohamed I. [1 ]
Wood-Trageser, Michelle [2 ]
Patel, Krishna [2 ]
Specht, Susan [2 ]
Sasatomi, Eizaburo [3 ]
Sun, Weijing [4 ]
Demetris, Anthony [5 ]
机构
[1] Univ Pittsburgh, Med Ctr, Presbyterian Shadyside, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Dept Pathol & Lab Med, Chapel Hill, NC USA
[4] Kansas Univ, Med Ctr, Lawrence, KS USA
[5] UPMC Montefiore, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1750
引用
收藏
页码:633 / 633
页数:1
相关论文
共 50 条
  • [1] Cholangiocarcinoma: Era of Immune Check-Point Inhibitors
    El Hag, Mohamed I.
    Wood-Trageser, Michelle
    Patel, Krishna
    Specht, Susan
    Sasatomi, Eizaburo
    Sun, Weijing
    Demetris, Anthony
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 633 - 633
  • [2] Targeted Interleukin 2 and synergy with immune check-point inhibitors
    Hutmacher-Berndt, Cornelia Deborah
    Neri, Dario
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [3] Immune check-point in endometrial cancer
    De Felice, Francesca
    Marchetti, Claudia
    Tombolini, Vincenzo
    Panici, P. Benedetti
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (08) : 910 - 916
  • [4] CHECK-POINT INHIBITORS AND THEIR KIDNEY INVOLVEMENT
    Villagrasa, Tania
    Luis Garcia, Jose
    Jimenez Mendoza, Sonia Cleofe
    Lado Fuentes, Mario
    Livianos Arias-Camison, Paloma
    Giovanna Dangelo, Maria
    Munar Vila, Maria Antonia
    Azkarate, Aitor
    Boyeras, Barbara
    Gomez Marques, Gonzalo
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 251 - 251
  • [5] Immune check-point in glioblastoma multiforme
    De Felice, F.
    Pranno, N.
    Marampon, F.
    Musio, D.
    Salducci, M.
    Polimeni, A.
    Tombolini, V.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 138 : 60 - 69
  • [6] Immune check-point in endometrial cancer
    Francesca De Felice
    Claudia Marchetti
    Vincenzo Tombolini
    P. Benedetti Panici
    [J]. International Journal of Clinical Oncology, 2019, 24 : 910 - 916
  • [7] MYOCARDITIS SECONDARY TO IMMUNE CHECK-POINT INHIBITORS: DIFFICULTIES IN ARRHYTHMIA MANAGEMENT
    Stringer, Bryan F.
    Kethireddy, Nikhila
    Rizkallah, Alain
    Darsaklis, Konstadina
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2694 - 2694
  • [8] Chemotherapy Plus Immune Check-Point Inhibitors in Metastatic Bladder Cancer
    Soares, Adriana
    Carmo, Rafael
    Rodrigues, Catarina
    Grilo, Ines Teles
    Grande, Enrique
    [J]. BLADDER CANCER, 2020, 6 (01) : 1 - 8
  • [9] Immune check-point in cervical cancer
    De Felice, F.
    Marchetti, C.
    Palaia, I.
    Ostuni, R.
    Muzii, L.
    Tombolini, V.
    Panici, P. Benedetti
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 40 - 43
  • [10] Renal damage secondary to check-point inhibitors
    Moliz, Candela
    Cavero, Teresa
    Morales, Enrique
    Gutierrez, Eduardo
    Alonso, Marina
    Praga, Manuel
    [J]. NEFROLOGIA, 2020, 40 (02): : 206 - 208